We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+3.59%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$4.43B
AUM Growth
-$11.5M
Cap. Flow
+$137M
Cap. Flow %
3.08%
Top 10 Hldgs %
37.18%
Holding
3,745
New
225
Increased
1,516
Reduced
1,175
Closed
233

Sector Composition

Rank Sector Weight
1 Technology 15.96%
2 Healthcare 9.75%
3 Financials 7.52%
4 Communication Services 4.86%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FV icon
2926
First Trust Dorsey Wright Focus 5 ETF
FV
$3.77B
$2.25K ﹤0.01%
41
FFWM
2927
DELISTED
First Foundation Inc
FFWM
$2.24K ﹤0.01%
432
-428
-50% -$2.29K
BRSL
2928
Brightstar Lottery PLC
BRSL
$2.03B
$2.23K ﹤0.01%
+137
New +$2.37K
APPN icon
2929
Appian
APPN
$2.48B
$2.22K ﹤0.01%
77
-17
-18% -$556
SWIM icon
2930
Latham Group
SWIM
$880M
$2.22K ﹤0.01%
+345
New +$2.32K
UDOW icon
2931
ProShares UltraPro Dow 30
UDOW
$940M
$2.22K ﹤0.01%
50
USFR icon
2932
WisdomTree Floating Rate Treasury Fund
USFR
$18.4B
$2.21K ﹤0.01%
44
FBT icon
2933
First Trust NYSE Arca Biotechnology Index Fund
FBT
$2.78B
$2.21K ﹤0.01%
13
NABL icon
2934
N-able
NABL
$940M
$2.21K ﹤0.01%
311
+52
+20% +$463
DNLI icon
2935
Denali Therapeutics
DNLI
$3.97B
$2.2K ﹤0.01%
162
+63
+64% +$1.21K
PFSI icon
2936
PennyMac Financial
PFSI
$4.02B
$2.2K ﹤0.01%
22
-2
-8% -$205
RXRX icon
2937
Recursion Pharmaceuticals
RXRX
$1.73B
$2.2K ﹤0.01%
393
+75
+24% +$547
YEXT icon
2938
Yext
YEXT
$574M
$2.2K ﹤0.01%
357
+54
+18% +$349
SDGR icon
2939
Schrodinger
SDGR
$1.36B
$2.19K ﹤0.01%
111
+47
+73% +$1.06K
NWBI icon
2940
Northwest Bancshares
NWBI
$2.28B
$2.18K ﹤0.01%
182
RPAY icon
2941
Repay Holdings
RPAY
$327M
$2.16K ﹤0.01%
+388
New +$2.67K
SCSC icon
2942
Scansource
SCSC
$1.12B
$2.14K ﹤0.01%
+63
New +$2.57K
NUVL
2943
DELISTED
Nuvalent
NUVL
$2.13K ﹤0.01%
30
+29
+2,900% +$2.27K
EGBN icon
2944
Eagle Bancorp
EGBN
$845M
$2.13K ﹤0.01%
102
RUM icon
2945
RUM Group Inc
RUM
$1.76B
$2.12K ﹤0.01%
300
GRW
2946
TCW ETF Trust TCW Durable Growth ETF
GRW
$66.8M
$2.12K ﹤0.01%
+64
New +$2.15K
OIS icon
2947
Oil States International
OIS
$491M
$2.12K ﹤0.01%
+411
New +$2.16K
DGII icon
2948
Digi International
DGII
$3.1B
$2.12K ﹤0.01%
+76
New +$2.35K
HBI
2949
DELISTED
Hanesbrands
HBI
$2.11K ﹤0.01%
366
-302
-45% -$2.12K
QCRH icon
2950
QCR Holdings
QCRH
$1.7B
$2.1K ﹤0.01%
29

Similar funds

Parallel Advisors's Q1 2025 Portfolio in Review

As of Q1 2025, Parallel Advisors held 3,745 positions worth $4.43B, down 0.26% from $4.45B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Parallel Advisors deployed $137M of net new capital in Q1 2025, opening 225 new positions and adding to 1,516 existing holdings. Its largest new stake was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Palantir, an estimated $25.2M trimmed.

  • Parallel Advisors's largest Q1 2025 buy was Avantis US Large Cap Value ETF: 6,987 shares worth $456K.
  • Parallel Advisors added most to Microsoft in Q1 2025, an estimated $39.4M increase.
  • Parallel Advisors's biggest Q1 2025 reduction was Palantir, cutting an estimated $25.2M.
  • Parallel Advisors fully exited Inari Medical, Inc. Common Stock in Q1 2025, selling an estimated $2.68M.
  • Parallel Advisors's ten largest holdings make up 37% of its $4.43B portfolio in Q1 2025.
  • Parallel Advisors opened 225 new positions and closed 233 in Q1 2025.
  • Parallel Advisors's portfolio value fell 0.26% quarter-over-quarter to $4.43B.

Based on Parallel Advisors's 13F filing for Q1 2025, filed 8 Apr 2025.